Joining the Impact Circle is 100% tax deductible. If you would like to pay for your membership via check, securities, donor-advised funds, or some other way, contact Lisa Palma.

If you would like more information on available matching opportunities for first-time members, contact Lisa Palma as well.  

Our central hypothesis is that treatment with Gly-Low will slow aging by targeting multiple known longevity pathways to improve human healthspan. By winning the Impact Circle we are not able to put it in a clinical trial.  

The group’s $100,000 award will enable Buck professor Lisa Ellerby, PhD, and former Buck postdoctoral fellow Barbara Bailus, PhD, to work on further developing their novel delivery system to bring various therapeutics into the brain, and they are hijacking the “good” parts of the Zika virus to do it.

The Buck's 2022 Impact Circle supported a first-ever pilot study taking place now to look at the effects of a ketogenic supplement in older adults.